Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report

RATIONALE: As the initial treatment of rapidly progressive interstitial lung disease (RPILD) with antimelanoma differentiation-associated gene 5 antibody (anti-MDA5 Ab)-positive dermatomyositis (DM) patients, a combination of corticosteroids, cyclophosphamide, and calcineurin inhibitor is recommende...

Descripción completa

Detalles Bibliográficos
Autores principales: Endo, Yushiro, Koga, Tomohiro, Suzuki, Takahisa, Hara, Kazusato, Ishida, Midori, Fujita, Yuya, Tsuji, Sosuke, Takatani, Ayuko, Shimizu, Toshimasa, Sumiyoshi, Remi, Igawa, Takashi, Umeda, Masataka, Fukui, Shoichi, Nishino, Ayako, Kawashiri, Shin-ya, Iwamoto, Naoki, Ichinose, Kunihiro, Tamai, Mami, Nakamura, Hideki, Origuchi, Tomoki, Kuwana, Masataka, Kawakami, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908626/
https://www.ncbi.nlm.nih.gov/pubmed/29642214
http://dx.doi.org/10.1097/MD.0000000000010436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908626/
https://www.ncbi.nlm.nih.gov/pubmed/29642214
http://dx.doi.org/10.1097/MD.0000000000010436

Ejemplares similares